The Economic Times
English Edition
| E-Paper
Search
+

    Moderna to join S&P 500, shares jump after hours

    Synopsis

    Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevating its market capitalization to about $100 billion.

    Reuters
    Britain's AstraZeneca said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
    Moderna Inc will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, S&P Dow Jones Indices said in a statement on Thursday.

    Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevating its market capitalization to about $100 billion.

    Britain's said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Read before you invest. Insights on AstraZeneca Pharma India Ltd.. Explore Now
    The Economic Times

    Stories you might be interested in